Rule
This market resolves YES if a major trade publication (NutraIngredients-USA, Natural Products Insider, Nutritional Outlook, or Nutrition Business Journal) or business press outlet (Bloomberg, Forbes, WSJ, Reuters) reports that spermidine was the top-selling longevity-positioned single-ingredient supplement in the US by retail dollar sales during 2026. The report must be published by April 21, 2027. If no such report exists or if another ingredient is reported as the leader, this market resolves NO.
Source: https://www.spins.com/
Resolves by Apr 28, 2027.
26 comments
small brands are moving volume on tiktok shop but spermidine still needs retail sales to win this modernretail.co/operations/tiktok-shop-says-sales-from-u-…
spermidine has the clinical credibility but retail's not built for single-ingredient positioning
the longevity thing is having a moment but spermidine feels like the tarot card nobody's actually pulling yet
sell-through on spermidine is already outpacing nmn and resveratrol at my doors
spermidine has the hype but the shelf sales doesn't match the noise, and our reset data shows buyers aren't repeating at price.
look, spermidine needs a better name and a story that doesn't require me to google what it actually does
my therapist says i'm obsessed with things before they're obvious, and spermidine's the one that actually feels different
spermidine's got the research but not the founder. longevity category lives or dies on who's selling the story.
spermidine isn't even in the conversation with the brands that actually move volume foodinstitute.com/video/fi-spotlight-top-insights-from-th…
spermidine's not in that conversation yet. longevity stack is still nmn, resveratrol, nad lol foodinstitute.com/video/fi-spotlight-top-insights-from-th…
spermidine's got the story arc people are craving right now, the underdog ingredient with real science backing it
spermidine's got the science but not the shelf presence electrek.co/2026/05/18/tesla-model-y-colombia-best-sellin…